Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-23-013006

Chief Technology Officer sold 2,302 shares at $25.97 ($59,790)

  • Chief Technology Officer acquired 37,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

HANLY ANN M. · Chief Technology Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-02-22 Grant or award : show line 1 in the form +37,500 119,505 D
2023-02-23 Sale : show line 2 in the form −2,302 $25.97 $59,790 117,203 D
Open-market sales · 2,302 sh · avg $25.97 · $59,790

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-22 Grant or award : show line 3 in the form Stock Option (Right to Buy) +55,000 55,000 D
Loading xslF345X03/doc4.xml…